Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07293559

Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States

IMPAACT 2046/UPLIFT (Understanding Practices of Lactation and Infant Feeding decisions Together with women with HIV) is a multi-site, mixed-methods, observational cohort study. The purpose of the study is to explore infant feeding preferences, practices, and outcomes among mothers with HIV and their families in the United States. It will employ both qualitative and quantitative research methods to address existing knowledge gaps and to understand the clinical, behavioral, and social factors influencing infant feeding decisions. As part of the study's mixed method approach, a longitudinal cohort study of mothers and their infants will be established. The study also aims to pilot a national registry of breastfeeding women living with HIV in the United States.

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

David Geffen School of Medicine at UCLA (CRS 5112), Los Angeles, California, United States

Loading trial locations.

About this study

This is a convergent mixed-method, multisite study to identify factors in infant feeding decisions and explore infant feeding perspectives, preferences, practices and outcomes among women with HIV in the US. Feasibility and acceptability of developing a national registry of breastfeeding women with HIV in the US will also be assessed. The study sites will enroll women with HIV who are pregnant or postpartum (PPWH), healthcare providers (HCPs) and ancillary healthcare professionals (AHPs), other influential individuals who contribute to infant feeding decisions, and pilot registry testers.

The study will be comprised of three core activities:

  • Core Activity 1: Will explore the multifaceted process of infant feeding decision-making, and describe clinical practice, and counseling approaches via in-depth interviews (IDIs) and surveys. IDIs will be completed with PPWH, influential people who contribute to infant feeding decisions, HCPs, and AHPs. HCPs and AHPs will also complete self-administered surveys, and site staff at each site will complete site-level surveys to inform a landscape analysis.
  • Core Activity 2: Will establish an observational prospective cohort of PPWH, and their liveborn infants, to examine current infant feeding practices and outcomes and their associated costs and cost benefits.
  • Core Activity 3: Will develop and pilot a national registry of breastfeeding women with HIV and assess its feasibility and acceptability among pilot registry testers.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Core Activity 1 Inclusion Criteria: Pregnant and Postpartum Women with HIV

  • Is of legal age or circumstance to provide independent informed consent
  • Belongs to one of the following five categories:
  • Is pregnant with a gestational age of 28 0/7 to 37 6/7 weeks at entry and is considering breastfeeding
  • Is pregnant with a gestational age of 28 0/7 to 37 6/7 weeks at entry and is not considering breastfeeding
  • Gave birth to a live born infant after 28 February 2023, is over 4 weeks postpartum, did not breastfeed for any duration and has no intent to breastfeed
  • Gave birth to a live born infant after 28 February 2023, is over 4 weeks postpartum, breastfed for less than four weeks, and has weaned
  • Gave birth to a live born infant after 28 February 2023, is over 4 weeks postpartum, and breastfed for four weeks or longer
  • Diagnosed with HIV prior to or during the pregnancy
  • If preferred language is other than English, is willing to participate in interviews with an available translator.

Core Activity 1 Inclusion Criteria: Healthcare Providers and Ancillary Healthcare Professionals

  • Is of legal age or circumstance to provide independent informed consent
  • Is a healthcare provider who self-identifies as an obstetrician, midwife, nurse, adult or pediatric infectious disease specialist, or advance practice provider who participated in the care of at least five PPWH and/or their infants over the three years prior to entry OR
  • Is an ancillary healthcare professional who self-identifies as a social worker, lactation support provider, patient navigator, pharmacist, doula who participated in the care of at least five PPWH and/or their infants over the three years prior to entry

Core Activity 1 Inclusion Criteria: Influential Individuals

  • Has been identified by a PPWH enrolled in Core Activity 1 as aware of her HIV status and contributing to her infant feeding decisions
  • Is of legal age or circumstance to provide independent informed consent
  • If preferred language is other than English, is willing to participate in interviews with an available translator.

Core Activity 2 Inclusion Criteria: Pregnant and Postpartum Women with HIV and their Infant

  • Is of legal age or circumstance to provide independent informed consent
  • Is pregnant with singleton fetus with a gestational age of ≥ 28 0/7 weeks at entry OR
  • Gave birth to a live born, singleton infant up to 7 days prior to entry
  • Diagnosed with HIV prior to or during the pregnancy
  • Expected to be available for the duration of follow-up

Core Activity 3 Inclusion Criteria: Breastfeeding Postpartum Women with HIV and their Infant

  • Is of legal age or circumstance to provide independent informed consent
  • Must be up to 7 days postpartum with live-born infant
  • Diagnosed with HIV prior to or during the pregnancy
  • Breastfed her infant for any duration

Core Activity 3 Inclusion Criteria: Pilot Registry Testers

  • Is of legal age or circumstance to provide independent informed consent
  • Working at a healthcare facility that provides care for women with HIV who are breastfeeding and/or their infants

Exclusion criteria

Core Activities 1-3

  • Has any condition identified during the screening period that, in the opinion of site investigator, would preclude informed consent, make study participation unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives

Treatment and study plan

No intervention provided in this study

Other

None; No intervention provided in this study

Primary outcomes

  1. CA 1: Factors influencing infant feeding decision

    Time frame: Within 28 days and 2 years of Enrollment

    Qualitative themes from in-depth interviews

  2. CA 1: Infants born to women with HIV who receive any breast milk

    Time frame: Monthly, through study completion, up until 5 years

    Binomial outcome from site level surveys

  3. CA 2: Infant feeding method chosen

    Time frame: At 48 weeks post birth

    Binary outcome

  4. CA 2: Breastfeeding initiation among those who intended to breastfeed

    Time frame: At 48 weeks post birth

    Binary outcome

  5. CA 2: Duration of breastfeeding among PPWH who breastfeed

    Time frame: Through 96 weeks post birth

    Numerical outcome

  6. CA 2: Completion of intended duration of breastfeeding

    Time frame: Through 96 weeks post birth

    Binary outcome

  7. CA 2: Mixed method analysis of infant feeding practices from in-depth interviews and survey data

    Time frame: At 48 weeks post birth

    Descriptive joint display table, with qualitative key themes and quantitative findings

  8. CA 2: Breast milk samples with detectable HIV DNA or RNA

    Time frame: Through 48 weeks post birth; At weaning up to 96 weeks post birth

    Binary outcome

  9. CA 2: Viral load measured in different breast milk compartments

    Time frame: Through 48 weeks post birth; At weaning up to 96 weeks post birth

    Numerical outcome

  10. CA 3: Data completed in registry

    Time frame: Through study completion, an average of 3 years

    Binary outcome; whether specified percentage of data is completed in registry

  11. CA 3: Median score on Feasibility of Intervention Measure, Acceptability of Intervention Measure and Appropriateness of Intervention Measures

    Time frame: Through study completion, an average of 3 years

    Numerical outcome

  12. CA 3: Completion of two visit entries for at least three eligible participants

    Time frame: Through study completion, an average of 3 years

    Binary outcome; whether sites complete entries

Secondary outcomes

  1. CA 1: Approaches to support infant feeding decisions and improve quality of care

    Time frame: Within 28 days and 2 years of Enrollment

    Qualitative themes from in-depth interviews

  2. CA 1: Descriptive results of current practices, burden, benefits and resources

    Time frame: Monthly, through study completion, up to 5 years

    Site surveys, provider surveys, In-depth Interviews

  3. CA 2: Median cost per postpartum woman with HIV and infant pair

    Time frame: Through study completion, up to 5 years

    Numerical outcome, by feeding approach

  4. CA 2: Cost effectiveness ratio presented as cost per quality adjusted life year saved in breastfeeding mother/infant pair

    Time frame: Through study completion, up to 5 years

    Numerical outcome

  5. CA 2: Cost per case of medical condition prevented by breastfeeding

    Time frame: Through study completion, up to 5 years

    Numerical outcome

  6. CA 2: Changes in scores of mental health and quality of life surveys

    Time frame: At 20 Weeks, At 48 Weeks

    Numerical outcome, by infant feeding method

  7. CA 2: Satisfaction with infant feeding decision and decision regret survey scores

    Time frame: At 20 weeks, At 48 weeks

    Numerical outcome, by infant feeding method

  8. CA 2: Infant HIV acquisition

    Time frame: Through study completion, up to 96 weeks post birth

    Binary outcome, by infant feeding method

  9. CA 2: Infant weight-for-age, length-for-age, head circumference-for-age (by z-score for sex)

    Time frame: At 20 weeks, At 48 weeks

    Numerical outcome

  10. CA 2: Score classification of each Ages and Stages developmental area

    Time frame: At 20 weeks, At 48 weeks

    Ordinal outcome

  11. CA 2: Plasma HIV viral load

    Time frame: Through 48 weeks post birth, At weaning up to 96 weeks post birth

    Numerical outcome and categorical outcome

  12. CA 2: Number of copies of HIV DNA or RNA per mL of milk

    Time frame: Through 48 weeks post birth, At weaning up to 96 weeks post birth

    Numerical outcome

Study contacts

Contact information is provided by the study sponsor or research team.

Lisa Levy

CONTACT

[email protected]

202-884-8480

Sponsors and collaborators

Lead sponsor

International Maternal Pediatric Adolescent AIDS Clinical Trials Group

Network

Collaborators

  • Centers for Disease Control and Prevention
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • National Institute of Allergy and Infectious Diseases (NIAID)
  • University of Colorado, Denver

Registry information

Acronym: UPLIFT

Important dates

Study start
2026
Primary completion
2031
Study completion
2031
First posted
Dec 19, 2025
Registry last updated
Mar 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.